Citation
Hundley WG et al. Statins and left ventricular ejection fraction following doxorubicin treatment. NEJM Evidence. 2022;1(9). DOI.
Publication
Statins and left ventricular ejection fraction following doxorubicin treatment
The PREVENT randomized trial, led by W. Gregory Hundley, evaluated atorvastatin for limiting declines in cardiac function during and after doxorubicin treatment. I served as the primary biostatistician responsible for the statistical analyses.
Hundley WG et al.
NEJM Evidence · 2022